Project Details
Description
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults with Mixed Dyslipidemia
| Status | Active |
|---|---|
| Effective start/end date | 3/1/21 → 3/31/25 |
Funding
- ARROWHEAD PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.